Skip to content

Agenda

7:00 – 7:30 am Breakout Check-in & Networking Breakfast
Sponsored by:
Bayer
7:30 – 8:15 am Breakfast Breakout Sessions
Dry Eye

Participants:
John Sheppard, MD, President – Virginia Eye Consultants
Edward Holland, MD, Director, Cornea Services – Cincinnati Eye Institute
Michael Ackermann, PhD, VP, Neurostimulation – Allergan
Amir Shojaei, VP & Development Lead for Ophthalmics – Shire

MIGS

Participants:
Richard Lewis, MD, Clinician – Sacramento Eye Consultants
Richard Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants
Chris Calcaterra, Chief Commercial Officer – Glaukos

Refractive Correction

Participants:
Eric Donnenfeld, MD, Clinical Professor, Ophthalmology – NYU
Rajesh Rajpal, MD, Chief Medical Officer – Avedro
John Berdahl, MD – Vance Thompson Vision
Vance Thompson, MD – Vance Thompson Vision

Gene & Stem Cell Therapies

Participants:
Jay Duker, MD, Founder – Hemera Biosciences
Jeffrey Marrazzo, CEO – Spark Therapeutics
Sue Washer, President & CEO – AGTC
Susan Benton, Head, Ophthalmics Business Development – Shire

Breakfast with the FDA

Participants:
Wiley Chambers, MD, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Kuldev Singh, MD, Professor – Stanford University
Elizabeth Yeu, MD – Virginia Eye Consultants

7:45 – 8:30 am General Check-in & Networking Breakfast
Sponsored by:
Bayer
8:30 – 8:45 am Welcome & Chairman’s 2016 Year in Review
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
8:45 – 10:30 am Anterior Segment Company Showcase
Co-Moderated By:
Christy Shaffer, PhD, General Partner – Hatteras Venture Partners
Catherine Truitt, Head, Search and Evaluation – Alcon

Company Presentations
10:30 – 11:00 am Morning Networking & Refreshment Break
Sponsored by:
Santen
11:00 am – 12:38 pm Posterior Segment Company Showcase
Co-Moderated By:
Peggy Hawkins, Business Development & Venture Management – Santen
Tom Cordaro, Head, Ophthalmology Pipeline – Bayer

Company Presentations
12:38 – 12:43 pm Private Funding Trends Presentation
Jonathan Norris, Managing Director – SVB
12:43 – 1:25 pm Networking Lunch
Sponsored by:
Abbott
1:25 – 1:50 pm OIS Industry Tribute to Allergan
Interviewed By:
William J. Link, PhD, Managing Director – Versant Ventures

Award Recipients:
Gavin Herbert, Founder
David Pyott, Former CEO

1:50 – 2:20 pm BUILDING A GLOBAL OPHTHALMIC FRANCHISE
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus

Participants:
Robert Dempsey, Franchise Head, Ophthalmics – Shire
Jerry St. Peter, VP & Head, Sun Ophthalmics – Sun Pharmaceutical Industries
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
Calvin Roberts, MD, SVP & Chief Medical Officer – Bausch + Lomb
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec

2:20 – 2:50 pm Afternoon Networking & Refreshment Break
Sponsored by:
Santen
2:50 – 2:55 pm Ophthalmic Innovation 2016 – “A View from the AAO”
David Parke, II, MD, CEO – American Academy of Ophthalmology (AAO)
2:55 – 3:00 pm Ophthalmic Innovation 2016 – “A View from the NEI”
Mala Dutta, PhD, Lead, Office of Translational Research, National Eye Institute – NIH
3:00 – 3:05 pm A View of the Public Ophthalmology Market & Exit Trends
Joe Gilliam, Managing Director, Healthcare Investment Banking – J.P. Morgan Securities
3:05 – 3:10 pm Introduction of the OIS Index
Michael Lachman, Founder – EyeQ Research
3:10 – 3:58 pm Public Device & BioPharma Ophthalmology Company Showcase
Moderated By:
Tom Salemi, Content Director – Healthegy

Company Presentations
3:58 – 4:30 pm Innovative Financing Options in Ophthalmology
Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners

Participants:
Sean Ianchulev, MD, MPH, Clinical Associate Professor – UCSF
Laurent Attias, Head of Strategy, BD&L and M&A – Alcon
Nir Ellenbogen, Managing Director – Eye-Lens Pte Ltd
Jeffry Weinhuff, Managing Partner – Visionary Venture Fund
Patricia Zilliox, PhD, Chief Drug Development Officer – Foundation Fighting Blindness

4:30 – 5:10 pm Masters of the Industry
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec

Participants:
Flemming Ornskov, MD, CEO – Shire
Mike Ball, CEO – Alcon
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director – Versant Ventures
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec
William Meury, Chief Commercial Officer – Allergan

5:10 – 5:15 pm Closing Remarks
William J. Link, PhD, Managing Director – Versant Ventures
5:15 – 6:15 pm Networking Reception
Sponsored by:
Alcon
Scroll To Top